Role of Class II MHC Antigens in Neurologic Diseases
Role of Class II MHC Antigens in Neurologic Diseases
批准号:
6383526
负责人:
Jenny P Ting
金额:
$32.61万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-15 至 2006-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): MHC class II molecules are expressed in
the central nervous system (CNS) during a number of neurologic disorders and
demyelinating disease. In a majority of these diseases, T cells are generally
absent in the affected CNS. To address the importance of class II MHC in CNS
disorders, we have characterized two models of demyelination that exhibit class
II MHC hyper-expression on microglial cells. Characterizations of these disease
models show that the deletion of class II MHC caused the alleviation of overt
symptoms, reduced neuropathology/demyelination, reduced microglial
activation/proliferation and reduced production of inflammatory cytokines. Most
intriguingly, the role of class II MHC is unaffected by the absence of T cells
in RAGb mice, but dependent on an intact class II MHC cytoplasmic tail. This
caused us to propose that class II may serve an in vivo role in signal
transduction, distinct from its conventional biologic role in antigen
presenting. The Aims are:
1.Analyze a transgenic mouse strain, H-2M for its response to cuprizone
treatment. If conventional antigen processing is not important, then the
deletion of H-2M should not affect cuprizone-induced demyelination.
2.Analyze how class II MHC and T cells affect the remyelination process. Recent
studies in our laboratory have demonstrated that inflammatory cytokines are
necessary for optimal remyelination. The presence of MHC class II causes
enhanced cytokine expression, therefore it is timely to determine the role of
MHC during remyelination, and if lymphocytes are involved in this process.
3. Determine novel mediators of class II MHC-mediated signaling. We will
determine if recently discovered mediators of class II signaling, cell
activation and proliferation are affected in microglia/macrophages.
4. Identify genes that are activated upon class II MHC engagement. in a
microglial-macrophage line by Affy metrix screening, and assess the status of
these genes in the cuprizone model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
-
批准号:10654660
-
项目类别:
-
资助金额:$90.61万
-
财政年份:2019
-
负责人:Jenny P Ting
-
依托单位:
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
-
批准号:10451800
-
项目类别:
-
资助金额:$90.55万
-
财政年份:2019
-
负责人:Jenny P Ting
-
依托单位:
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
-
批准号:10217045
-
项目类别:
-
资助金额:$92.43万
-
财政年份:2019
-
负责人:Jenny P Ting
-
依托单位:
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
-
批准号:10019472
-
项目类别:
-
资助金额:$92.59万
-
财政年份:2019
-
负责人:Jenny P Ting
-
依托单位:
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
-
批准号:9229872
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2014
-
负责人:Jenny P Ting
-
依托单位:
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
-
批准号:8642227
-
项目类别:
-
资助金额:$360.31万
-
财政年份:2014
-
负责人:Jenny P Ting
-
依托单位:
Engineering Monodisperse Particulate Vaccines to Tailor Immunological Responses
-
批准号:9337971
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2014
-
负责人:Jenny P Ting
-
依托单位:
Discovery of New Innate Immune Pathways in Viral Recognition
-
批准号:8653231
-
项目类别:
-
资助金额:$316.37万
-
财政年份:2014
-
负责人:Jenny P Ting
-
依托单位:
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
-
批准号:9307701
-
项目类别:
-
资助金额:$466.6万
-
财政年份:2014
-
负责人:Jenny P Ting
-
依托单位:
Novel Nucleic Acid Sensing NLRs and Innate Immunity to Viruses
-
批准号:9233910
-
项目类别:
-
资助金额:$41.68万
-
财政年份:2014
-
负责人:Jenny P Ting
-
依托单位:
NOD-like Receptors in Intestinal Inflammation
-
批准号:10447741
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2013
-
负责人:Jenny P Ting
-
依托单位:
NOD-like Receptors in Intestinal Inflammation
-
批准号:10216239
-
项目类别:
-
资助金额:$35.25万
-
财政年份:2013
-
负责人:Jenny P Ting
-
依托单位:
NOD-like Receptors in Intestinal Inflammation
-
批准号:10642795
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2013
-
负责人:Jenny P Ting
-
依托单位:
Novel roles of the NLR protein in host response against WNV and DENV
-
批准号:8375882
-
项目类别:
-
资助金额:$25.69万
-
财政年份:2012
-
负责人:Jenny P Ting
-
依托单位:
Novel roles of the NLR protein in host response against WNV and DENV
-
批准号:8234189
-
项目类别:
-
资助金额:$24.52万
-
财政年份:2011
-
负责人:Jenny P Ting
-
依托单位:
Colitis, colon cancer and the NLR family
-
批准号:8445358
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2011
-
负责人:Jenny P Ting
-
依托单位:
Colitis, colon cancer and the NLR family
-
批准号:8840704
-
项目类别:
-
资助金额:$9.09万
-
财政年份:2011
-
负责人:Jenny P Ting
-
依托单位:
Colitis, colon cancer and the NLR family
-
批准号:8043373
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2011
-
负责人:Jenny P Ting
-
依托单位:
Colitis, colon cancer and the NLR family
-
批准号:8260497
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2011
-
负责人:Jenny P Ting
-
依托单位:
Immunology Program
-
批准号:8340200
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2011
-
负责人:Jenny P Ting
-
依托单位:
海外基金